nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—Benzphetamine—Tamoxifen—pancreatic cancer	0.443	1	CrCrCtD
Methamphetamine—SLC22A3—Irinotecan—pancreatic cancer	0.232	0.695	CbGbCtD
Methamphetamine—CYP2D6—Tamoxifen—pancreatic cancer	0.0449	0.134	CbGbCtD
Methamphetamine—CYP2D6—Erlotinib—pancreatic cancer	0.0382	0.114	CbGbCtD
Methamphetamine—CYP2D6—Doxorubicin—pancreatic cancer	0.0188	0.0564	CbGbCtD
Methamphetamine—ADRA2A—Signaling Pathways—MEN1—pancreatic cancer	4.34e-05	0.000195	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—JAG1—pancreatic cancer	4.33e-05	0.000194	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOTCH3—pancreatic cancer	4.31e-05	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—PIK3CB—pancreatic cancer	4.3e-05	0.000192	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—PIK3CA—pancreatic cancer	4.25e-05	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PIK3CG—pancreatic cancer	4.24e-05	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—SRC—pancreatic cancer	4.24e-05	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GCG—pancreatic cancer	4.22e-05	0.000189	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PIK3CB—pancreatic cancer	4.16e-05	0.000186	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	4.15e-05	0.000186	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SHH—pancreatic cancer	4.14e-05	0.000186	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—VEGFA—pancreatic cancer	4.13e-05	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOTCH4—pancreatic cancer	4.12e-05	0.000184	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—pancreatic cancer	4.12e-05	0.000184	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TP53—pancreatic cancer	4.11e-05	0.000184	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.11e-05	0.000184	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IAPP—pancreatic cancer	4.09e-05	0.000183	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CNR1—pancreatic cancer	4.08e-05	0.000183	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—NRAS—pancreatic cancer	4.08e-05	0.000183	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TGFB1—pancreatic cancer	4.06e-05	0.000182	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PIK3CD—pancreatic cancer	4.03e-05	0.000181	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AGTR1—pancreatic cancer	4.03e-05	0.00018	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CD44—pancreatic cancer	3.99e-05	0.000179	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—STK11—pancreatic cancer	3.97e-05	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CG—pancreatic cancer	3.96e-05	0.000177	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GCG—pancreatic cancer	3.94e-05	0.000177	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HRAS—pancreatic cancer	3.94e-05	0.000176	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTHLH—pancreatic cancer	3.93e-05	0.000176	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTCH1—pancreatic cancer	3.93e-05	0.000176	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.84e-05	0.000172	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GCG—pancreatic cancer	3.83e-05	0.000172	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—TYMS—pancreatic cancer	3.81e-05	0.000171	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TGFB1—pancreatic cancer	3.79e-05	0.00017	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—APOE—pancreatic cancer	3.77e-05	0.000169	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AGTR1—pancreatic cancer	3.76e-05	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—KRAS—pancreatic cancer	3.76e-05	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PIK3CD—pancreatic cancer	3.73e-05	0.000167	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—STK11—pancreatic cancer	3.71e-05	0.000166	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—STK11—pancreatic cancer	3.6e-05	0.000161	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	3.6e-05	0.000161	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SST—pancreatic cancer	3.59e-05	0.000161	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTEN—pancreatic cancer	3.59e-05	0.000161	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.58e-05	0.00016	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.54e-05	0.000159	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—DPYD—pancreatic cancer	3.54e-05	0.000159	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—JAG1—pancreatic cancer	3.52e-05	0.000157	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PIK3CB—pancreatic cancer	3.52e-05	0.000157	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—KRAS—pancreatic cancer	3.51e-05	0.000157	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOTCH3—pancreatic cancer	3.5e-05	0.000157	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—pancreatic cancer	3.48e-05	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CD—pancreatic cancer	3.48e-05	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SMAD4—pancreatic cancer	3.48e-05	0.000156	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—AKT1—pancreatic cancer	3.47e-05	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—PIK3CA—pancreatic cancer	3.45e-05	0.000155	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—SRC—pancreatic cancer	3.44e-05	0.000154	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CXCL8—pancreatic cancer	3.44e-05	0.000154	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CG—pancreatic cancer	3.4e-05	0.000152	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HES1—pancreatic cancer	3.39e-05	0.000152	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	3.36e-05	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—VEGFA—pancreatic cancer	3.35e-05	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.34e-05	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TP53—pancreatic cancer	3.34e-05	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CNR1—pancreatic cancer	3.32e-05	0.000149	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—NRAS—pancreatic cancer	3.31e-05	0.000148	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PPARG—pancreatic cancer	3.28e-05	0.000147	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PIK3CB—pancreatic cancer	3.25e-05	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SMAD4—pancreatic cancer	3.25e-05	0.000145	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—PIK3CA—pancreatic cancer	3.22e-05	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CG—pancreatic cancer	3.22e-05	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CXCL8—pancreatic cancer	3.21e-05	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GCG—pancreatic cancer	3.2e-05	0.000143	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—HRAS—pancreatic cancer	3.19e-05	0.000143	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HES1—pancreatic cancer	3.17e-05	0.000142	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CXCL8—pancreatic cancer	3.12e-05	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TP53—pancreatic cancer	3.12e-05	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.12e-05	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—APOE—pancreatic cancer	3.1e-05	0.000139	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TYMS—pancreatic cancer	3.1e-05	0.000139	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TGFB1—pancreatic cancer	3.08e-05	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AGTR1—pancreatic cancer	3.06e-05	0.000137	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTEN—pancreatic cancer	3.04e-05	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CB—pancreatic cancer	3.04e-05	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—STK11—pancreatic cancer	3.01e-05	0.000135	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CD—pancreatic cancer	2.99e-05	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—HRAS—pancreatic cancer	2.98e-05	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TERT—pancreatic cancer	2.97e-05	0.000133	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CXCL8—pancreatic cancer	2.92e-05	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—KRAS—pancreatic cancer	2.85e-05	0.000128	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HIF1A—pancreatic cancer	2.84e-05	0.000127	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TSC2—pancreatic cancer	2.84e-05	0.000127	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	2.83e-05	0.000127	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—AKT1—pancreatic cancer	2.82e-05	0.000126	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CG—pancreatic cancer	2.8e-05	0.000125	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TERT—pancreatic cancer	2.78e-05	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APOE—pancreatic cancer	2.78e-05	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KDR—pancreatic cancer	2.72e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.72e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPARG—pancreatic cancer	2.7e-05	0.000121	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HIF1A—pancreatic cancer	2.66e-05	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TSC2—pancreatic cancer	2.65e-05	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SMAD4—pancreatic cancer	2.64e-05	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—AKT1—pancreatic cancer	2.63e-05	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—PIK3CA—pancreatic cancer	2.62e-05	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	2.61e-05	0.000117	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CB—pancreatic cancer	2.61e-05	0.000117	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CD44—pancreatic cancer	2.6e-05	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APOE—pancreatic cancer	2.59e-05	0.000116	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NFKBIA—pancreatic cancer	2.59e-05	0.000116	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—pancreatic cancer	2.58e-05	0.000116	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HES1—pancreatic cancer	2.57e-05	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOTCH1—pancreatic cancer	2.56e-05	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KDR—pancreatic cancer	2.54e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TP53—pancreatic cancer	2.53e-05	0.000113	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PIK3CA—pancreatic cancer	2.53e-05	0.000113	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—APOE—pancreatic cancer	2.52e-05	0.000113	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CG—pancreatic cancer	2.51e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—NRAS—pancreatic cancer	2.51e-05	0.000112	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GCG—pancreatic cancer	2.5e-05	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EGF—pancreatic cancer	2.48e-05	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	2.47e-05	0.00011	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CD—pancreatic cancer	2.46e-05	0.00011	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—HRAS—pancreatic cancer	2.42e-05	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NFKBIA—pancreatic cancer	2.42e-05	0.000108	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOTCH1—pancreatic cancer	2.39e-05	0.000107	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCL8—pancreatic cancer	2.37e-05	0.000106	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—STK11—pancreatic cancer	2.35e-05	0.000105	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CG—pancreatic cancer	2.34e-05	0.000105	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—NRAS—pancreatic cancer	2.34e-05	0.000105	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EGF—pancreatic cancer	2.31e-05	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—EGFR—pancreatic cancer	2.28e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CG—pancreatic cancer	2.27e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TERT—pancreatic cancer	2.26e-05	0.000101	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTEN—pancreatic cancer	2.25e-05	0.000101	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CD—pancreatic cancer	2.2e-05	9.87e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARG—pancreatic cancer	2.19e-05	9.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.18e-05	9.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HIF1A—pancreatic cancer	2.16e-05	9.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—KRAS—pancreatic cancer	2.16e-05	9.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	2.15e-05	9.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CB—pancreatic cancer	2.14e-05	9.61e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PIK3CA—pancreatic cancer	2.14e-05	9.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—AKT1—pancreatic cancer	2.14e-05	9.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—EGFR—pancreatic cancer	2.13e-05	9.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—pancreatic cancer	2.13e-05	9.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	2.11e-05	9.43e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—AKT1—pancreatic cancer	2.07e-05	9.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	2.06e-05	9.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CD—pancreatic cancer	2.06e-05	9.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.04e-05	9.13e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.02e-05	9.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—KRAS—pancreatic cancer	2.01e-05	9.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	2e-05	8.95e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.98e-05	8.87e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.96e-05	8.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.94e-05	8.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	1.92e-05	8.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.9e-05	8.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	1.9e-05	8.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	1.88e-05	8.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTEN—pancreatic cancer	1.85e-05	8.3e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CA—pancreatic cancer	1.85e-05	8.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	1.84e-05	8.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	1.83e-05	8.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CB—pancreatic cancer	1.79e-05	8.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	1.78e-05	7.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	1.77e-05	7.91e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—AKT1—pancreatic cancer	1.75e-05	7.84e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	1.74e-05	7.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	1.73e-05	7.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—pancreatic cancer	1.73e-05	7.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL8—pancreatic cancer	1.72e-05	7.72e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	1.72e-05	7.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HRAS—pancreatic cancer	1.71e-05	7.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	1.7e-05	7.62e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	1.67e-05	7.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	1.67e-05	7.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—AKT1—pancreatic cancer	1.66e-05	7.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	1.66e-05	7.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.66e-05	7.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CASP3—pancreatic cancer	1.65e-05	7.39e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APOE—pancreatic cancer	1.64e-05	7.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	1.64e-05	7.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	1.62e-05	7.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCND1—pancreatic cancer	1.61e-05	7.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	1.59e-05	7.12e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CA—pancreatic cancer	1.59e-05	7.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	1.56e-05	6.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	1.55e-05	6.94e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	1.54e-05	6.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	1.51e-05	6.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTEN—pancreatic cancer	1.51e-05	6.74e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.5e-05	6.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	1.5e-05	6.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	1.48e-05	6.65e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.48e-05	6.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	1.48e-05	6.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.46e-05	6.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	1.44e-05	6.44e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.43e-05	6.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	1.4e-05	6.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	1.4e-05	6.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	1.39e-05	6.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	1.39e-05	6.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	1.38e-05	6.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	1.38e-05	6.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	1.38e-05	6.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.35e-05	6.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	1.35e-05	6.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	1.34e-05	6e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	1.31e-05	5.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	1.3e-05	5.84e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.3e-05	5.83e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—AKT1—pancreatic cancer	1.3e-05	5.82e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.29e-05	5.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	1.29e-05	5.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	1.28e-05	5.75e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	1.27e-05	5.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	1.27e-05	5.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	1.26e-05	5.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	1.26e-05	5.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	1.23e-05	5.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	1.19e-05	5.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	1.17e-05	5.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	1.17e-05	5.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	1.14e-05	5.09e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.14e-05	5.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	1.13e-05	5.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	1.13e-05	5.04e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.12e-05	5.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	1.12e-05	5.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	1.09e-05	4.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	1.08e-05	4.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—AKT1—pancreatic cancer	1.07e-05	4.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	1.06e-05	4.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	1.06e-05	4.74e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	1.05e-05	4.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	1.04e-05	4.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	1.02e-05	4.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	1.01e-05	4.53e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTEN—pancreatic cancer	9.81e-06	4.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	9.67e-06	4.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	9.56e-06	4.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	8.93e-06	4e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	8.88e-06	3.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AKT1—pancreatic cancer	8.68e-06	3.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	8.59e-06	3.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	8.22e-06	3.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	7.25e-06	3.25e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	6.92e-06	3.1e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AKT1—pancreatic cancer	5.65e-06	2.53e-05	CbGpPWpGaD
Methamphetamine—Pseudoephedrine—TNF—pancreatic cancer	2.34e-06	0.505	CrCbGaD
Methamphetamine—Nateglinide—PPARG—pancreatic cancer	2.3e-06	0.495	CrCbGaD
